Kala Bio (KALA) Operating Expenses (2016 - 2026)

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Kala Bio was $20.99 million, down 49.0% year-over-year; for FY2025, it was $39.16 million, down 4.4% from FY2024.

• Annual Operating Expenses shows a five-year compound annual growth rate of -17.5% (FY2020 to FY2025).
• In prior years, Kala Bio's Operating Expenses was $40.98 million in FY2024 (+3.3%), $39.66 million in FY2023 (-53.7%), $85.6 million in FY2022 (-39.5%) and $141.49 million in FY2021 (+37.9%).
• The Q2 2026 figure stands as the lowest quarterly Operating Expenses in data going back to Q2 2016.
• On a year-over-year basis, Operating Expenses increased in three of the last eight quarters, with an average decline of 21.3%.
• The strongest year-over-year quarter for Operating Expenses in the past five years was Q4 2021, with growth of 55.9%; the weakest was Q2 2026, with a decline of 84.4%.
• According to Business Quant data, Operating Expenses for the three prior quarters was $1.8 million (Q1 2026), $10.23 million (Q4 2025) and $7.24 million (Q3 2025).